Non-invasive Identification of Metabolic Dysfunction-associated Steatotic Liver Disease Patients Eligible for Resmetirom Treatment
- PMID: 40228592
- DOI: 10.1016/j.cgh.2025.02.014
Non-invasive Identification of Metabolic Dysfunction-associated Steatotic Liver Disease Patients Eligible for Resmetirom Treatment
LinkOut - more resources
Full Text Sources
